Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031220728Completed
Trial of edonerpic in hemiparesis, ischemic stroke and intracerebral hemorrhage (ICH) (2 arms), sponsored by Takeda Science Foundation Japan Society For The Promotion of Science. Primary endpoint: Change in AMPA receptor binding per brain voxel. Started Apr 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031220728.